Pfizer’s respiratory syncytial virus vaccine was more than 90% effective among older adults during the first season it was available, including among those with underlying conditions or severe disease ...
As respiratory virus season begins, pediatric experts are preparing for an expected rise in cases of Respiratory Syncytial ...
The respiratory syncytial virus vaccine is effective in reducing emergency visits, hospitalizations, and severe illness in ...
Revaccination with mRNA-1345 against RSV at 12 months was noninferior to primary vaccination among adults aged 50 years and older.
As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid ...
Objectives The common cold is the main cause of medical time loss in elite sport. Rapid diagnosis has been a challenge that may be amenable to molecular point-of-care testing (POCT). Methods We ...
Abstract: In this study, we developed an AI model to predict Respiratory Distress Syndrome (RDS) in premature infants, aiming to reduce unnecessary treatment with artificial pulmonary surfactant. We ...
Abstract: Millimeter-wave radar has attracted increasing attention for respiratory monitoring due to its non-contact operation and privacy-preserving characteristics. Nevertheless, extracting ...
Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Find tips and support for family caregiving, from financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback